• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝胰十二指肠切除术联合门静脉和肝动脉切除治疗局部进展期胆管癌:超扩大手术的短期和长期疗效。

Hepatopancreatoduodenectomy with simultaneous resection of the portal vein and hepatic artery for locally advanced cholangiocarcinoma: Short- and long-term outcomes of superextended surgery.

机构信息

Department of Gastrointestinal Surgery, Aichi Cancer Center Hospital, Nagoya, Japan.

Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.

出版信息

J Hepatobiliary Pancreat Sci. 2021 Apr;28(4):376-386. doi: 10.1002/jhbp.914. Epub 2021 Mar 12.

DOI:10.1002/jhbp.914
PMID:33587829
Abstract

BACKGROUND

Only a few authors have reported negative results for hepatopancreatoduodenectomy (HPD) with simultaneous resection of the portal vein and hepatic artery in a limited number of patients. The aim of the current study was to outline our experience with this superextended surgery and to discuss its clinical value.

METHODS

Medical records of consecutive patients who underwent resection of perihilar cholangiocarcinoma between 2007 and 2020 were retrospectively reviewed.

RESULTS

During the study interval, 650 patients with perihilar cholangiocarcinoma underwent resection. The superextended surgery was performed in only nine (1.4%) patients. Left or right trisectionectomy was primarily performed. For portal vein reconstruction, external iliac vein graft was required in seven patients. For hepatic artery reconstruction, rotating left gastric artery was often used. The median operative time was 870 minutes and blood loss was 2,598 mL. Postoperatively, pancreatic fistula and liver failure occurred in all patients, followed by intraabdominal abscess (n = 8), and bacteremia (n = 4). One patient died on day 86 due to multiple organ failure. Two patients survived for more than 7 years.

CONCLUSIONS

HPD with simultaneous resection of the portal vein and hepatic artery is demanding but worth performing as the last option, with careful patient selection in experienced centers.

摘要

背景

仅有少数作者报道了少数患者行肝胰十二指肠切除术(HPD)联合门静脉和肝动脉切除的阴性结果。本研究旨在总结我们对此超扩大手术的经验并探讨其临床价值。

方法

回顾性分析 2007 年至 2020 年间连续接受肝门部胆管癌切除术的患者的病历。

结果

研究期间,650 例肝门部胆管癌患者接受了切除术。仅 9 例(1.4%)患者行超扩大手术。主要行左或右三叶切除术。7 例患者需要行髂外静脉移植重建门静脉,旋转胃左动脉常用于肝动脉重建。中位手术时间为 870 分钟,出血量为 2598 毫升。术后所有患者均发生胰瘘和肝功能衰竭,随后发生腹腔脓肿(n=8)和菌血症(n=4)。1 例患者因多器官功能衰竭于术后 86 天死亡。2 例患者存活超过 7 年。

结论

HPD 联合门静脉和肝动脉切除具有挑战性,但作为最后的选择是值得的,在有经验的中心应谨慎选择患者。

相似文献

1
Hepatopancreatoduodenectomy with simultaneous resection of the portal vein and hepatic artery for locally advanced cholangiocarcinoma: Short- and long-term outcomes of superextended surgery.肝胰十二指肠切除术联合门静脉和肝动脉切除治疗局部进展期胆管癌:超扩大手术的短期和长期疗效。
J Hepatobiliary Pancreat Sci. 2021 Apr;28(4):376-386. doi: 10.1002/jhbp.914. Epub 2021 Mar 12.
2
Hepatectomy with simultaneous resection of the portal vein and hepatic artery for advanced perihilar cholangiocarcinoma: an audit of 50 consecutive cases.肝切除术联合门静脉和肝动脉切除治疗高位肝门部胆管癌:50 例连续病例的回顾性分析。
Ann Surg. 2010 Jul;252(1):115-23. doi: 10.1097/SLA.0b013e3181e463a7.
3
Hepatopancreatoduodenectomy with simultaneous resection of the portal vein and hepatic artery: Ultimate superextended surgery for advanced perihilar cholangiocarcinoma.门静脉和肝动脉同时切除的肝胰十二指肠切除术:晚期肝门部胆管癌的终极超扩大手术
J Hepatobiliary Pancreat Sci. 2022 Jun;29(6):597-599. doi: 10.1002/jhbp.1102. Epub 2021 Dec 30.
4
Right hepatectomy for a detoured left hepatic artery in hilar cholangiocarcinoma-report of a rare but rational resection.肝门部胆管癌合并左肝动脉绕行的右半肝切除术——1例罕见但合理的肝切除报告
World J Surg Oncol. 2016 Nov 16;14(1):288. doi: 10.1186/s12957-016-1045-8.
5
Surgical technique of hepatectomy combined with simultaneous resection of hepatic artery and portal vein for perihilar cholangiocarcinoma (with video).肝门部胆管癌肝切除术联合肝动脉及门静脉同期切除的手术技术(附视频)
J Hepatobiliary Pancreat Sci. 2014 Aug;21(8):E57-61. doi: 10.1002/jhbp.121. Epub 2014 Jun 10.
6
Combined vascular resection in operative resection for hilar cholangiocarcinoma: does it work or not?肝门部胆管癌手术切除中的联合血管切除:是否有效?
Surgery. 2007 May;141(5):581-8. doi: 10.1016/j.surg.2006.09.016. Epub 2007 Mar 23.
7
Portal vein resection for hilar cholangiocarcinoma.肝门部胆管癌的门静脉切除术
Am Surg. 2006 Jul;72(7):599-604; discussion 604-5.
8
[Evaluations of total hilar en bloc resection and reconstruction in comparison with portal vein resection and reconstruction in treatment of perihilar cholangiocarcinoma].[肝门部胆管癌治疗中全肝门整块切除重建与门静脉切除重建的对比评估]
Zhonghua Wai Ke Za Zhi. 2021 Jan 1;59(1):32-39. doi: 10.3760/cma.j.cn112139-20200728-00591.
9
Liver Transection-First Approach in Hepatopancreatoduodenectomy for Hilar Cholangiocarcinoma: A Safe and Secure Technique for the Early Assessment of Curable Resection and Vascular Reconstruction.肝切除术优先在肝胰十二指肠切除术治疗肝门部胆管癌中的应用:一种安全、可靠的技术,用于早期评估可切除性和血管重建。
Ann Surg Oncol. 2021 Jun;28(6):2988-2989. doi: 10.1245/s10434-020-09303-x. Epub 2020 Nov 9.
10
Right trisectionectomy with principle en bloc portal vein resection for right-sided hilar cholangiocarcinoma: no-touch technique.右三叶切除术联合整块门静脉切除治疗右肝门部胆管癌:无接触技术。
Ann Surg Oncol. 2012 Apr;19(4):1324-5. doi: 10.1245/s10434-011-2072-x. Epub 2011 Oct 15.

引用本文的文献

1
Perihilar cholangiocarcinoma: a surgeon's perspective.肝门部胆管癌:外科医生的视角
ILIVER. 2022 Apr 5;1(1):12-24. doi: 10.1016/j.iliver.2022.03.004. eCollection 2022 Mar.
2
Indications and Outcomes of Hepatopancreatoduodenectomy for Gallbladder Carcinoma and Extrahepatic Cholangiocarcinoma: A Single Center Retrospective Study.胆囊癌和肝外胆管癌胰十二指肠切除术的适应症及预后:一项单中心回顾性研究
JGH Open. 2025 Mar 24;9(3):e70144. doi: 10.1002/jgh3.70144. eCollection 2025 Mar.
3
High preoperative Glasgow prognostic score increases a risk of hospital mortality in elderly patients with perihilar cholangiocarcinoma.
术前高格拉斯哥预后评分增加了老年肝门部胆管癌患者的医院死亡风险。
J Hepatobiliary Pancreat Sci. 2025 Apr;32(4):298-310. doi: 10.1002/jhbp.12111. Epub 2025 Feb 13.
4
Residual biliary intraepithelial neoplasia without malignant transformation at resection margin for perihilar cholangiocarcinoma does not require expanded resection: a dual center retrospective study.肝门周围胆管癌切缘残留无恶性转化的胆管上皮内瘤变不需要扩大切除:一项双中心回顾性研究。
World J Surg Oncol. 2024 Jun 21;22(1):161. doi: 10.1186/s12957-024-03395-5.
5
Endoscopic sphincterotomy and endoscopic biliary stenting do not affect the sensitivity of transpapillary forceps biopsy for the diagnosis of bile duct adenocarcinoma.内镜下括约肌切开术和内镜胆管支架置入术不影响经乳头活检钳诊断胆管腺癌的敏感性。
BMC Gastroenterol. 2022 Jul 5;22(1):329. doi: 10.1186/s12876-022-02402-x.
6
Concomitant Hepatic Artery Resection for Advanced Perihilar Cholangiocarcinoma: A Narrative Review.晚期肝门部胆管癌同期肝动脉切除术:一项叙述性综述
Cancers (Basel). 2022 May 27;14(11):2672. doi: 10.3390/cancers14112672.
7
Vascular Resection in Perihilar Cholangiocarcinoma.肝门部胆管癌的血管切除
Cancers (Basel). 2021 Oct 21;13(21):5278. doi: 10.3390/cancers13215278.
8
Current role of hepatopancreatoduodenectomy for the management of gallbladder cancer and extrahepatic cholangiocarcinoma: A systematic review.肝胰十二指肠切除术在胆囊癌和肝外胆管癌治疗中的当前作用:一项系统评价
World J Gastrointest Oncol. 2021 Jun 15;13(6):625-637. doi: 10.4251/wjgo.v13.i6.625.